PAYAL CHRISTIAN: Open Payments
NPI 1871992933 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 64 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $260 |
| Ardelyx, Inc. | 13 | $240 |
| ABBVIE INC. | 13 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $151 |
| Aimmune Therapeutics, Inc. | 3 | $79 |
| QOL Medical, LLC | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: REZDIFFRA, IBSRELA, XIFAXAN, ENTYVIO, CREON, RINVOQ, Sucraid, DUPIXENT.
Industry payments across MD — which companies pay providers there.
